On March 9th, 2012 a proposal to lease and develop a public museum on Parcel 9 near the Rose Kennedy Greenway was submitted by the Boston History Center and Museum, Inc. However, last week the Massachusetts Department of Transportation eliminated the museum from consideration for occupation of Parcel 9. The History Center claimed that the proposed project would generate substantial economic activity in the area while providing Boston with a state-of-the-art facility to house Boston’s rich history. Unfortunately, the DOT was uninterested in the construction of a museum in the downtown area. No word on what will occupy the parcel yet, but the DOT is looking to create complementary linkages between parcel 9 & 7 to facilitate an active center.
Related Post
Here’s why some planners say creating public parks boosts commercial development
By Andy Peters When the NFL in 2014 named Minneapolis host city for Super Bowl LII, local leaders realized they needed to create more public space for fans to gather before and after the big game. Though they didn’t know it, officials were also about to add credence to a high-stakes theory in commercial real estate […]
Residential tower proposed at Alewife site once considered for labs
By Greg Ryan A Boston-based real estate developer is proposing a 12-story, 227-unit residential building in Alewife, the Cambridge neighborhood that was put under a construction moratorium for more than a year out of fear it would be overrun by life sciences labs. Boylston Properties is hosting community meetings next week to discuss its plans to […]
Senate to vote on plans for new soccer stadium Thursday
By Trajan Warren The state Senate will vote on a $2.8 billion economic development bill on Thursday which includes plans to transform a 43-acre parcel in Everett into a stadium for the New England Revolution. A separate bill passed by the House in June — H.4804 — didn’t include plans for the stadium. If passed by the Senate, […]
Eli Lilly buys Waltham biotech for $3.2B
By Hannah Green Eli Lilly and Co. is buying a Waltham biotech in a deal valued at around $3.2 billion. The startup being acquired is Morphic Holding Inc. (NASDAQ: MORF), a Waltham company working on treatments for chronic diseases such as types of inflammatory bowel disease. Indianapolis-based Lilly (NYSE: LLY) plans to acquire all outstanding shares of […]
Moderna has opened its new, larger headquarters in Cambridge
By Hannah Green Moderna Inc. officially opened the doors to its new global headquarters on Wednesday, fulfilling its plan to bring its research and development operations under one roof. The Cambridge drugmaker has moved into a six-floor, 462,000-square-foot office and lab building at 325 Binney St. Moderna (Nasdaq: MRNA) first shared its intention to move into a new Cambridge […]
BU buys Allston site approved for 17-story residential tower
By Greg Ryan Boston University has agreed to pay $19.8 million to purchase a site on the edge of its campus that has city approval for a 17-story tower with more than 250 residences. The property is next to the planned future home of West Station, a new transit hub featuring commuter-rail service. The transaction means that […]